What is Interleukin 6? Interleukin 6 or IL6 is a protein, a member of the IL-6 Family with polypeptide cytokines and four alpha-helix structures. The molecular mass of IL6 is21 – 29 kDa. It plays a vital role in producing neutrophils in[…]
Read MoreAntibodies are giant Y-shaped proteins known as immunoglobulins produced by B cells as a part of the flexible human response when encountering a foreign molecule. Many researchers employ epitopes to identify and detect the target protein of interest in various applications because[…]
Read MoreRESEARCH-GNG: Prashant Thakre, Chinmay Umbarkar, Komal Talreja, Sidhant Vyas, Jawad Baksh, Kalyani Dange, Akash Nehare, Vilas Danav, Ashwin Kashikar, Supriya Kashikar and Vinod Agarkar MARKETING-GNG: Mohammad Abdul, Rashmi Upadhyay and Supriya Kashikar Introduction Proteins are the most abundant macromolecules in the living[...]
Read MoreIn the dynamic field of biotechnology, recombinant protein production has been a game-changer, revolutionizing our ability to create a wide range of proteins with diverse applications. The process involves recombinant DNA technology to engineer microorganisms or cells to produce specific proteins, and[…]
Read MoreAntibody Library, Phage Display Antibody Library Antibodies are an essential component of our immune system, playing a crucial role in identifying and neutralizing pathogens. Beyond their natural function in the body, antibodies have found extensive application in medical research and the development[…]
Read MoreIn immunology and medical research, antibodies are critical in detecting and neutralizing harmful pathogens. Our immune system produces these Y-shaped proteins to target specific invaders, such as bacteria, viruses, and toxins. In scientific research and clinical applications, Monoclonal And Polyclonal Antibodies are[…]
Read MoreTransmembrane TNF-α, a forerunner of the dissolvable form of TNF-α, is conveyed on activated macrophages, lymphocytes, and other cell types. So after processing by TFN-α-converting enzyme, the dissolvable form of TNF-α spilt from transmembrane TNF-α and mediated its biological activity through tiding[…]
Read MoreThe very first monoclonal antibody approved by the U.S. FDA (Food and Drug Administration) in 1997 ushered a new era in therapeutic applications for patients. A clinical breakthrough was acknowledged in the 1990s when there was the successful development of a humanized[…]
Read MoreCancer has it all captured right from the ancient animals to the sufficient wildlife and humans. There are much fewer known cancers that affect the wildlife, yet there has been proven research that allows one to study and know from. The Cancer[…]
Read MoreThe progress in engineering and clinical development has been remarkable in the development of Therapeutic Antibody for 40 years, with the work done by Kohler and Milstein. The US FDA has led approval to the 21 antibodies for cancer immunotherapy. The approved[…]
Read More